STAT

At a dangerous point in the Ebola outbreak, residents increase cooperation with containment efforts

The people living in the current Ebola hot spot in the DRC are beginning to comprehend more fully the danger the virus poses — a welcome development in an outbreak…
A man displays an Ebola information leaflet for residents in Mangina, Democratic Republic of Congo. Source: Al-hadji Kudra Maliro/AP

The Ebola outbreak in the Democratic Republic of the Congo has reached a dangerous phase, with the response operation acknowledging it hasn’t got a full picture of where the virus is spreading in a large urban center.

That concerning development is tempered slightly by signs that people living in Beni, the current hot spot of transmission, are beginning to comprehend more fully the danger the virus poses, said a senior World Health Organization official.

That understanding is translating into better cooperation — a welcome development in an outbreak response that has had more than its share of bad luck.

“There is underground community transmission in Beni. It may not be at a very intense level. But it is enough to continue and drive transmission in this

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readPsychology
Opinion: In A Medical Emergency, Who In Your Social Network Will Call For Help Quickest?
Applying the "strength of weak ties" theory to medicine, a weakly connected familiar in your social network can be the outside voice of reason who isn't afraid to call for…
STAT3 min read
Why Are Elite Athletes Different Than The Rest Of Us? Take A Look At Their Microbes
Elite athletes really are different from you and me. Or, at least their gut microbes are. Scientists who analyzed stool samples of 15 runners a week before and after they competed in the 2015 Boston Marathon found unusually high levels of one particu
STAT2 min read
AbbVie To Acquire Allergan For $63 Billion In Megamerger Of Pharma Giants
AbbVie said Tuesday it will acquire Allergan for $63 billion — the latest megamerger between two pharma giants seeking new ways to grow.